183677-71-6 - Names and Identifiers
183677-71-6 - Physico-chemical Properties
Molecular Formula | C11H14BBrO2
|
Molar Mass | 268.95 |
Density | 1.33±0.1 g/cm3(Predicted) |
Melting Point | 109-111°C |
Boling Point | 331.0±25.0 °C(Predicted) |
Storage Condition | 2-8°C |
MDL | MFCD01318105 |
183677-71-6 - Risk and Safety
Safety Description | S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
|
183677-71-6 - Upstream Downstream Industry
183677-71-6 - Introduction
4-BROMOBENZENEBORONIC ACID NEOPENTYL GLYCOL ESTER is an organic compound. The following is a description of its nature, use, preparation and safety information:
Nature:
-Appearance: The common form is white crystalline powder.
-Solubility: Soluble in some organic solvents, such as dimethylformamide (DMF), dichloromethane (DCM) and dimethyl sulfoxide (DMSO).
-Melting point: About 140-145°C.
Use:
- 4-BROMOBENZENEBORONIC ACID NEOPENTYL GLYCOL ESTER is commonly used as an important intermediate in organic synthesis.
-It can be used to synthesize various organic compounds, such as drugs, pesticides and dyes.
-In chemical reactions, it can participate in the cross-coupling reaction of Phenylboronic acid (Suzuki reaction) and the Kujin reaction.
Method:
4-BROMOBENZENEBORONIC ACID NEOPENTYL GLYCOL ESTER can be synthesized by the following steps:
1. First, 4-bromophenylboronic acid is reacted with neopentyl glycol in an organic solvent.
2. The reaction is usually carried out under an inert atmosphere, and a catalyst is added to promote the reaction.
3. After the reaction is completed, the target product is obtained through extraction and purification processes.
Safety Information:
- 4-BROMOBENZENEBORONIC ACID NEOPENTYL GLYCOL ESTER is less toxic and dangerous.
-During handling and use, laboratory safety procedures need to be followed.
-It may cause irritation to the eyes, skin and respiratory tract, so appropriate protective measures are required.
-When exposed to the compound, immediately flush the affected area with water and seek medical help if symptoms of discomfort occur.
Last Update:2024-04-09 21:01:54